Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Novo gets much-needed lift as Wegovy pill tops Wall Street forecasts

The drug’s third-quarter sales numbers came in well above consensus estimates, widening Novo’s early edge over Eli Lilly in the latest battleground for weight loss medicines.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Health & Medicine

More from Wednesday 4 November →